Table_1_Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease.docx by Dong Wang (73290)

“…Moreover, we observed a significant increase in IL-10 levels after ruxolitinib treatment (P=0.025) and a remarkable decrease in levels of suppression of tumorigenicity 2 (ST2) from 229.90 ng/ml to 72.65 ng/ml. …”

Variation of average codeword length (ACL) by number of edges. by Dario Elias (8882177)

“…A positive variation indicates a decrease in the ACL. …”

NF-κB and apoptotic signals <i>in vivo</i>. by Naoki Takada (2728912)

NF-κβ, COX, and ROS involvement in EP bridge formation. by Brett G. Zani (254541)

“…TNF-α or PGE₂ (10 µM) decreased EP bridges in only EPs/FBs. #p<0.05 vs. control, n = 3−4. …”

Circular Dichroism analysis, PPIase activity and nickel regulation of <i>H</i>. <i>pylori</i> WT and mutant SlyD proteins. by Milica Denic (9987685)

Optimal hydrated lime concentration in asphalt binder to improve photo degradation resistance by André Gustavo Banja (5110844)

Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-I<i>α</i> by Lin Li (28817)

“…The activation of PKG–1α was then studied using targeted proteomic analysis (MRM-MS) checking the phosphorylation state of the autophosphorylation domain (aa42-94). Significant decrease in phosphorylation of PKG-Iα at Ser50, Ser72, Ser89 was induced by HR injury while SCU treatment significantly increased the phosphorylation of PKG-Iα, not only at Ser50, Ser72 and Ser89, but also at Ser44 and Thr58 (two novel phosphorylation domains). …”

Histone deacetylase (HDAC) inhibitor assessment. by Ilona Tkachyova (343715)

“…ITF 2357, an HDAC inhibitor which is structurally and functionally similar to SAHA, produced a dose-response curve with IC₅₀ of 0.2 μM. …”

Plk1 inhibition suppresses the clonogenic potential of SUM149 and SUM159. by Antonio Giordano (55096)

“…(B) EC₅₀ was defined as 50% colony inhibition. Single agents EC₅₀ were reported for each TNBC cell line and drug. …”

Regulation of MCF-7 mammosphere formation by breast cancer promoters and metformin. by Ji-Won Jung (194917)

“…On the other hand, metformin treatment decreased MCF-7 proliferation (mean ± SD, n = 3). *, <i>P</i><0.05; **, <i>P</i><0.01; ***, <i>P</i><0.001. …”

Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Accelerated Optical Projection Tomography Applied to <i>In Vivo</i> Imaging of Zebrafish by Teresa Correia (3956129)

“…In this work, we demonstrate that the use of an iterative algorithm to reconstruct sparsely sampled OPT data sets can provide useful 3-D images with 50 or fewer projections, thereby significantly decreasing the minimum acquisition time and light dose while maintaining image quality. …”

Table 1_Elucidating the effects of nine-steaming-nine-drying on the morphology, metabolomic profile, and active ingredients of Polygonatum sibiricum Redouté.xls by Rui Wang (52434)

“…These alterations resulted in darker coloration, as evidenced by a significant decrease in L* values, elimination of tongue-numbing effects, enhanced sweetness, and improved quality of P. sibiricum Red. …”

Table1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”